Order Article Reprints

Jeon Y-H, Lee N, Yoo J, Won S, Shin S-k, Kim K-H, Park J-G, Kim M-G, Kim H-R, Oh K, et al. Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8⁺ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines. 2022; 10(4):805. https://doi.org/10.3390/biomedicines10040805

Jeon, Yun-Hui, Namhee Lee, Jiyoon Yoo, Solchan Won, Suk-kyung Shin, Kyu-Hwan Kim, Jun-Gyu Park, Min-Gang Kim, Hang-Rae Kim, Keunhee Oh, and et al. 2022. "Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8⁺ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy" Biomedicines 10, no. 4: 805. https://doi.org/10.3390/biomedicines10040805

Jeon, Y.-H., Lee, N., Yoo, J., Won, S., Shin, S.-k., Kim, K.-H., Park, J.-G., Kim, M.-G., Kim, H.-R., Oh, K., & Lee, D.-S. (2022). Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8⁺ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines, 10(4), 805. https://doi.org/10.3390/biomedicines10040805